시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
순환종양세포 시장 규모, 점유율, 성장 분석 : 기술별, 용도별, 제품별, 검체별, 최종 용도별, 지역별 - 산업 예측(2025-2032년)
Circulating Tumor Cell Market Size, Share, and Growth Analysis, By Technology, By Application, By Product, By Specimen, By End Use, By Region - Industry Forecast 2025-2032
상품코드 : 1687596
리서치사 : SkyQuest
발행일 : 2025년 03월
페이지 정보 : 영문 219 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,636,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,932,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,229,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

세계의 순환종양세포 시장 규모는 2023년에 122억 달러로 평가되며, 2024년 135억 5,000만 달러에서 2032년에는 314억 6,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 11.1%로 성장할 전망입니다.

세계 순환종양세포(CTC) 시장은 암 진단의 기술 혁신과 암 발병률 증가로 인해 역동적으로 성장하고 있습니다. 비침습적 진단 툴, 특히 CTC 분석에 대한 수요는 맞춤형 의료로의 전환과 암의 조기 발견에 대한 절박한 필요성에 의해 촉진되고 있습니다. 그러나 기술적 복잡성과 표준화 부족으로 인해 비침습적 진단 툴의 광범위한 보급을 가로막고 있습니다. 현재 ELISA법과 PCR법이 제품의 주류를 차지하고 있습니다. 북미가 큰 시장 점유율을 차지하고 있는 것은 탄탄한 의료 인프라에 기인합니다. 이 시장은 진화하는 의료 환경에 대응하고 환자 결과를 개선하기 위한 지속적인 연구 구상, 공동 연구 및 혁신적인 제품 개발로 특징지어집니다.

목차

서론

조사 방법

개요

시장 역학과 전망

주요 시장 인사이트

순환종양세포 시장 규모 : 기술별 & CAGR(2025-2032)

순환종양세포 시장 규모 : 용도별 & CAGR(2025-2032)

순환종양세포 시장 규모 : 제품별 & CAGR(2025-2032)

순환종양세포 시장 규모 : 검체별 & CAGR(2025-2032)

순환종양세포 시장 규모 : 최종 용도별 & CAGR(2025-2032)

순환종양세포 시장 규모 : 지역별 & CAGR(2025-2032)

경쟁 정보

주요 기업 개요

결론과 제안

KSA
영문 목차

영문목차

Global Circulating Tumor Cell Market size was valued at USD 12.2 billion in 2023 and is poised to grow from USD 13.55 billion in 2024 to USD 31.46 billion by 2032, growing at a CAGR of 11.1% during the forecast period (2025-2032).

The global Circulating Tumor Cell (CTC) market is witnessing dynamic growth, driven by innovations in cancer diagnostics and an increasing incidence of cancer. The demand for non-invasive diagnostic tools, particularly CTC analysis, is fueled by a shift towards personalized medicine and a pressing need for early cancer detection. However, challenges such as technological complexities and the lack of standardization hinder broader adoption. Currently, ELISA and PCR-based methods dominate the product landscape. North America commands a significant market share attributed to its robust healthcare infrastructure. The market is characterized by continuous research initiatives, collaborative efforts, and innovative product developments aimed at addressing the evolving medical landscape and enhancing patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Circulating Tumor Cell market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Circulating Tumor Cell Market Segments Analysis

Global Circulating Tumor Cell Market is segmented by Technology, Application, Product, Specimen, End Use and region. Based on Technology, the market is segmented into CTC detection & enrichment methods, CTC Direct Detection Methods and CTC Analysis. Based on Application, the market is segmented into Clinical/ Liquid Biopsy and Research. Based on Product, the market is segmented into Kits & Reagents, Blood Collection Tubes and Devices or Systems. Based on specimen, the market is segmented into Blood, Bone Marrow and Other Body Fluids. Based on End Use, the market is segmented into Research and academic institutes, Hospital and clinics and Diagnostic centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Circulating Tumor Cell Market

The rising incidence of cancer worldwide has intensified the demand for advanced diagnostic tools, with circulating tumor cell (CTC) analysis gaining prominence as a non-invasive and valuable technique for cancer detection and monitoring. Additionally, the focus on personalized medicine and the urgency for early cancer diagnosis are driving the adoption of CTC technologies. This growing need for effective diagnostic solutions is reshaping the global landscape of cancer management and treatment, fostering innovation and advancements in the CTC market, which aims to provide better outcomes for patients through improved detection and monitoring capabilities.

Restraints in the Global Circulating Tumor Cell Market

One of the primary challenges facing the global circulating tumor cell (CTC) market is the technological complexity involved in CTC analysis. This intricacy complicates the process and highlights the need for standardization across various methodologies, which hinders widespread acceptance and implementation. Furthermore, concerns regarding the reliability and reproducibility of CTC results create additional barriers, making it difficult for these techniques to be integrated into standard clinical practices. As such, these factors collectively contribute to limiting the overall growth and adoption of CTC technologies in the healthcare sector, restraining market potential.

Market Trends of the Global Circulating Tumor Cell Market

The global circulating tumor cell (CTC) market is witnessing a significant trend characterized by the increasing integration of CTC analysis into routine clinical practice. This shift is driven by the technology's ability to facilitate real-time cancer progression tracking and treatment response evaluation. Advances in innovative technologies such as microfluidic systems and sophisticated molecular detection techniques are enhancing the precision and sensitivity of CTC analysis. Additionally, the rising awareness and adoption of liquid biopsy methods for cancer diagnostics underscore the critical role of CTCs as valuable biomarkers. This convergence of technology and clinical application is poised to revolutionize cancer care and diagnosis.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Circulating Tumor Cell Market Size by Technology & CAGR (2025-2032)

Global Circulating Tumor Cell Market Size by Application & CAGR (2025-2032)

Global Circulating Tumor Cell Market Size by Product & CAGR (2025-2032)

Global Circulating Tumor Cell Market Size by End Use & CAGR (2025-2032)

Global Circulating Tumor Cell Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기